Stock GLENMARK GLENMARK PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Glenmark Pharmaceuticals Limited

Equities

GLENMARK

INE935A01035

Delayed NSE India S.E.
Other stock markets
 09:05:05 27/06/2024 BST 		5-day change 1st Jan Change
1,225 INR -0.12% Intraday chart for Glenmark Pharmaceuticals Limited -1.28% +43.50%
06-12 India Equities Close Higher Ahead of US Inflation Data MT
06-12 Glenmark Pharmaceuticals Gets US FDA Final Nod for Esomeprazole Magnesium Capsules MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
India Equities Close Higher Ahead of US Inflation Data
Glenmark Pharmaceuticals Gets US FDA Final Nod for Esomeprazole Magnesium Capsules
Assertio Therapeutics Names Brendan O'Grady as Chief Executive
INDIA STOCKS-Metal stocks lead Indian shares higher
Glenmark Pharmaceuticals Widens Consolidated Net Loss in Fiscal Q4
INDIA STOCKS-Indian shares at record highs, boosted by pharma stocks, Adani Ports
Glenmark Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2025
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Glenmark Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Glenmark Pharmaceuticals Limited Recommends Dividend for the Financial Year 2023-24
India's Sensex Ends Down, Nifty Up Ahead of National Poll Outcome
Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India
Glenmark Pharmaceuticals Receives ANDA Approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5%
Glenmark Pharmaceuticals to Acquire 26% Stake in Renewable Energy Company
Glenmark Pharmaceuticals Limited Appoints Shweta Munjal as Chief Communications & CSR Officer
Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines
Glenmark Pharmaceuticals Limited Receives Anda Approval for Acetaminophen and Ibuprofen Tablets, 250 Mg/125 Mg
Glenmark Lifesciences' Net Profit Slides in Fiscal Q4
Glenmark Pharmaceuticals Limited Announces Board Changes
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLENMARK Stock
  4. News Glenmark Pharmaceuticals Limited
  5. Other languages